AAAAAA

   
Results: 1-11 |
Results: 11
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization
Authors: Munck, A Bonacorsi, S Mariani-Kurkdjian, P Lebourgeois, M Gerardin, M Brahimi, N Navarro, J Bingen, E
Citation: A. Munck et al., Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization, PEDIAT PULM, 32(4), 2001, pp. 288-292
Commensal Escherichia coli isolates are phylogenetically distributed amonggeographically distinct human populations
Authors: Duriez, P Clermont, O Bonacorsi, S Bingen, E Chaventre, A Elion, J Picard, B Denamur, E
Citation: P. Duriez et al., Commensal Escherichia coli isolates are phylogenetically distributed amonggeographically distinct human populations, MICROBI-SGM, 147, 2001, pp. 1671-1676
Virulence factors associated with E-coli K1 neonatal meningitis
Authors: Bonacorsi, S Houdoin, V Bingen, E
Citation: S. Bonacorsi et al., Virulence factors associated with E-coli K1 neonatal meningitis, ARCH PED, 8, 2001, pp. 726S-731S
Pertussis in neonates.
Authors: Aujard, Y Zabe-Desanges, C Six, C Goulet, V Bonacorsi, S
Citation: Y. Aujard et al., Pertussis in neonates., MED MAL INF, 31, 2001, pp. 39S-44S
The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli
Authors: Clermont, O Bonacorsi, S Bingen, E
Citation: O. Clermont et al., The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli, FEMS MICROB, 196(2), 2001, pp. 153-157
Automated Ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains
Authors: Clermont, O Cordevant, C Bonacorsi, S Marecat, A Lange, M Bingen, E
Citation: O. Clermont et al., Automated Ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains, J CLIN MICR, 39(12), 2001, pp. 4549-4553
Metabolism of [C-14] omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans
Authors: Iyer, RA Mitroka, J Malhotra, B Bonacorsi, S Waller, SC Rinehart, JK Roongta, VA Kripalani, K
Citation: Ra. Iyer et al., Metabolism of [C-14] omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans, DRUG META D, 29(1), 2001, pp. 60-69
Mechanisms of macrolide resistance in clinical group B streptococci isolated in France
Authors: Fitoussi, F Loukil, C Gros, I Clermont, O Mariani, P Bonacorsi, S Le Thomas, I Deforche, D Bingen, E
Citation: F. Fitoussi et al., Mechanisms of macrolide resistance in clinical group B streptococci isolated in France, ANTIM AG CH, 45(6), 2001, pp. 1889-1891
Early-onset neonatal Gardnerella vaginalis infections
Authors: Zabe-Desanges, C Rajguru-Kazemi, M Bedu, A Bonacorsi, S Aujard, Y
Citation: C. Zabe-desanges et al., Early-onset neonatal Gardnerella vaginalis infections, ARCH PED, 7(11), 2000, pp. 1242-1243
Rapid and simple determination of the Escherichia coli phylogenetic group
Authors: Clermont, O Bonacorsi, S Bingen, E
Citation: O. Clermont et al., Rapid and simple determination of the Escherichia coli phylogenetic group, APPL ENVIR, 66(10), 2000, pp. 4555-4558
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis
Authors: Bonacorsi, S Fitoussi, F Lhopital, S Bingen, E
Citation: S. Bonacorsi et al., Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis, ANTIM AG CH, 43(2), 1999, pp. 213-217
Risultati: 1-11 |